June 16, 2009 - In response to the molybdenum 99 (Mo-99) supply shortage, Covidien sent out a letter to its customers informing them of the anticipated Covidien generator and unit dose (UD) Tc 99m supply to the overall U.S., Canadian and Latin American markets through August 2009.

The update noted the National Research Universal (NRU) reactor in Chalk River, Canada, will be out of service for at least three months as reported by the Atomic Energy of Canada Ltd.; and the High Flux Reactor (HFR) in Petten, The Netherlands, has a planned shutdown in early July that is expected to last a few days.

Covidien has made arrangements through its diversified supply chain to the remaining online reactors in Belgium and South Africa, and have increased orders for Mo 99 from each reactor to partially offset the shortages caused by the HFR routine maintenance and ongoing NRU reactor shutdown.

Despite these efforts, the company expects there will still be a global shortage of Tc 99m generators during this period.

Covidien stated it should be able to supply its current customers, but not fully meet new demand coming from an influx of facilities seeking alternative suppliers of Mo-99. The company cautioned that at times it may not be able to fully meet even its current clients’ demand.

For more information: www.covidien.com


Related Content

News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
News | Artificial Intelligence

May 30, 2024 — Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) ...

Time May 30, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | Radiology Business

January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals ...

Time January 23, 2024
arrow
Subscribe Now